Concepedia

Ola Rizq

OR

Statistics

Publications

6

Citations

304

H-Index

6

Active since

2014

Affiliations

Chiba University(Current)

The University of Tokyo

Icahn School of Medicine at Mount Sinai

Chiba University Hospital

Dana-Farber Cancer Institute

Ola Rizq is an author at Chiba University specializing in life sciences, molecular biology, and epigenetics.

Publications per year

2014–2021

6

Publications

6

Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition

Ola Rizq, Naoya Mimura, Motohiko Oshima et al. · Clinical Cancer Research · 2017 · 83 citations · Full text

, , +17

Selective and Potent Akt Inhibition Triggers Anti-Myeloma Activities and Enhances Fatal Endoplasmic Reticulum Stress Induced by Proteasome Inhibition

Naoya Mimura, Teru Hideshima, Toshiyasu Shimomura et al. · Cancer Research · 2014 · 78 citations · Full text

, , +15

EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma

Yuko Kusakabe, Tetsuhiro Chiba, Motohiko Oshima et al. · Scientific Reports · 2021 · 43 citations · Full text

, , +14

The chromatin-binding protein Phf6 restricts the self-renewal of hematopoietic stem cells

Satoru Miyagi, Patrycja Sroczyńska, Yuko Kato et al. · Blood · 2019 · 40 citations · Full text

, , +14

Genetic and transcriptional landscape of plasma cells in POEMS syndrome

Yuhei Nagao, Naoya Mimura, June Takeda et al. · Leukemia · 2019 · 36 citations

, , +10

1–5 of 6